Urology Devices Market

Report Overview

The global urology devices market was pegged at US$ 36.5 billion in 2021 and is expected to witness a CAGR of 3.9% during the forecast period. 

Market Fundamentals 

Urology and nephrology devices are used for the treatment and diagnosis of renal diseases such as urinary incontinence, kidney stone, prostate cancer, chronic kidney diseases, pelvic organ prolapse, kidney failure, and urinary tract infection.  The kidney removes extra fluid and waste material from the blood by filtration as a byproduct in urine. If the kidney fails to do function its leads to anemia, arthritis, cardiac disease, high blood pressure, and many life-threatening diseases. According to the Centers for Disease Control and Prevention, in 2021, nearly 37 million people have chronic kidney diseases in the United States, 9 out of 10 adults do not know they have chronic kidney disease. It is more common in people aged around 65 years and older.

[6454334]

Market Dynamics

The global urology devices market is mainly driven by prevalence of kidney diseases, diabetes, prostate cancer, bladder cancer, high blood pressure, and other chronic kidney diseases. Additionally, increasing geriatric population, technological advancement, merger and acquisition of key players and government reimbursement policies are contributing market growth. Also, accuracy and precision of surgery, less recovery time, shorter hospital stay and decreased post operative complication are fueling the global urology devices market. However high cost of devices, expensive robotic surgical procedures and long time taken for research & development for device development are hampering the market growth.

Market Ecosystem

The global urology devices market has been analyzed from five perspectives: Product Type, Technology, Application, End Users, and Region

Urology Devices Market by Product Type

The global urology devices market has been segmented into endoscopy devices, benign prostatic hyperplasia treatment devices, dialysis equipment, urinary stone treatment devices, urinary incontinence, and pelvic organ prolapse devices. Prevalence of urological disorder, increasing chronic kidney diseases, and a rise in the number of kidney failure cases are contributing to the market growth of the dialysis equipment market. Moreover, technological advancement, the availability of portable dialysis devices, government policies, easily accessible reimbursement, and regulations on dialysis procedures are fueling the market growth. In April 2020 the Tablo® hemodialysis system received U.S. Food and Drug Administration clearance for home dialysis.

Urology Devices Market by Technology

[89765]

The global urology devices market has been segmented into robotic surgery and minimally invasive surgery. Minimally invasive surgery is leading the global market owing to less intervention, precision, and less recovery time, and overall cost saving are some of the driving factors of this segment. Moreover, shorten hospital stay, less complication post operative, and smaller incision are contributing the minimally invasive surgery market. For the robotic devices segment, evolving reimbursement policies, high research and development initiatives in devices, and new product launches are fueling the market growth. In May 2022, Ethicon part of Johnson and Johnson received FDA 510k clearance for MONARCH Endoscopic Robotic Platform Urology Procedures.

Urology Devices Market by Application

The global urology devices market has been segmented into ureteroscopy, lithotripsy, orchiopexy, vasectomy, cystoscopy, prostate procedures and others. Lithotripsy holds high market share owing to technological development, no surgical procedure required, low cost procedure, less recovery time, accurate and precise procedure. Additionally increasing patients with obesity and high blood pressure, rising cases of urolithiasis, and awareness about novel treatment procedures are contributing market growth. In July 2022, Calyxo raised $32.7 million In C funding to support novel treatments for kidney stones and this fund will be utilized for product development and expansion.

Urology Devices Market by Region

Based on region, the global urology devices market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is currently leading the global urology devices market. The large market share of North America is attributed to the presence of advanced healthcare system and developed infrastructure, favorable government initiatives, high prevalence of chronic kidney diseases, and increasing geriatric population. Additionally, in Europe, strong presence of key players, a rising geriatric population and increasing number of regulatory approved urology devices are helping to grow the European market. Also rising prevalence of urological disease, increasing awareness about chronic kidney diseases, and availability of advanced and precise urological devices market fueling the market growth in Europe.

Competitive Landscape

Major players operating in the global urology devices market are 

• Baxter International Inc
• Becton
• Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc
• Coloplast A/S
• Cook Medical
• Fresenius Medical Care AG & Co. KGaA
• HealthTronics, Inc
• Intuitive Surgical, Inc
• Johnson & Johnson
• Karl Storz SE & Co. KG
• Medtronic Plc
• Siemens Healthineers AG
• Olympus Corporation
• Richard Wolf GmbH
• Stryker Corporation
• Among others

Strategic Developments

• In Jan 2022, DaVita inc. announced that they acquired the Medsleuth transplant software company. Aim to provide better connectivity to transplant candidates, transport centers for greater outcome and experience for liver and kidney transplant patient
• In May 2022, DaVita and Medtronic announced that they will launch a new kidney health technology company. The company will be focusing on future-based kidney products, developing novel kidney care products, make dialysis treatment more affordable and accessible to patients
• In Dec 2020, Medtronic launched its first and only neonatal and pediatric acute dialysis machine in the U.S. market. It will provide continuous renal replacement therapy to pediatric and neonatal patients weighing between 2.5 and 10 kilograms.
• In June 2022, Quanta Dialysis Technologies Ltd had raised $245 million in the D Series round, this is the biggest funding round for any dialysis device company in history with the vision of making dialysis care more accessible and flexible.

Frequently Asked Questions About This Report